Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US00507K1034
Ticker AGN
Company ALLERGAN
Currency $
Price
Aware Investor Index (AII) 0.0001
Recommendation STRONG SELL
P/E 74.40
ROE 1.11 %
Capitalization 53,680,730,000 $
Dividend Yield 0.00 %
P/S 3.40
AII Position 710
P/E Position 663
ROE Position 719
Capitalization Position 163
Dividend Yield Position 594
Sales 15,787,400,000 $
10-Year Average Earnings 721,520,000 $
Shares Outstanding 337,000,000
Equity 65,131,000,000 $
Dividend per Share 0 $
Industry Pharmaceutical
Country United States
ALLERGAN Investor Relations Web Site http://www.allergan.com/INVESTORS







Sales:

YEAR MONTH AMOUNT
2018 12 15,787,400,000.00 $
2017 12 15,940,700,000.00 $
2016 12 14,570,600,000.00 $
2015 12 15,071,000,000.00 $
2014 12 13,062,300,000.00 $
2013 12 8,677,600,000.00 $
2012 12 5,914,900,000.00 $

Earnings:

YEAR MONTH AMOUNT
2018 12 -5,142,800,000.00 $
2017 12 -4,403,900,000.00 $
2016 12 14,695,000,000.00 $
2015 12 3,683,200,000.00 $
2014 12 -1,630,500,000.00 $
2013 12 -750,400,000.00 $
2012 12 97,300,000.00 $
2011 12 260,900,000.00 $
2010 12 184,400,000.00 $
2009 12 222,000,000.00 $

Equity:

YEAR MONTH AMOUNT
2018 12 65,131,000,000.00 $
2017 12 73,837,100,000.00 $
2016 12 76,200,500,000.00 $
2015 12 76,589,300,000.00 $
2014 12 28,335,500,000.00 $
2013 12 9,537,100,000.00 $
2012 12 3,856,400,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2018 12 337,000,000
2017 12 333,800,000
2016 12 384,900,000
2015 12 367,800,000
2014 12 219,700,000
2013 12 142,300,000
2012 12 128,400,000

 









Comments:

DATE COMMENT
2014-04-19 13:06:45 Equity increased after Warner Chilcott acquisition



Bloomberg News for ALLERGAN:



Google News for ALLERGAN:

The News Heater - 2 hours ago
Allergan plc (AGN) Beta Value Currently at 1.59: Risk Analysis?
The Allergan plc (NYSE:AGN) is going up by 1.00% in today's trading session, a rise equivalent to 1.59% of the stock's price from yesterday's ...
E Globalist
Here's Why Allergan is Outperforming Its Industry Of Late
Shares of Allergan plc AGN have risen 19.1% this year so far against ... AbbVie ABBV offered to buy Allergan in a cash-and-stock deal worth ...
Finch News
Endo, Allergan Nearing Deals to Limit Ohio Litigation Over Opioids ...
Top pharmaceutical companies Allergan (AGN - Get Report) and Endo International (ENDP - Get Report) are nearing a deals to avoid or limit ...
DFS News
Pounding the Pavement on Shares of Allergan Plc (AGN)
Allergan Plc (AGN)'s MACD Histogram reading is currently below the zero line, indicating a neutral or negative chart trend for the shares.
Yahoo Finance - 6 hours ago
Can Value Investors Consider Allergan (AGN) a Worthy Pick?
Let's put Allergan plc AGN stock into this equation and find out if it is a good choice for value-oriented investors right now, or if investors ...
TheStreet.com - 9 hours ago
Implied Volatility Surging for Allergan (AGN) Stock Options
Investors in Allergan plc AGN need to pay close attention to the stock based on moves in the options market lately. That is because the Aug 16, ...
Physician's Weekly
Buy AbbVie Stock Because You 'Can't Ignore' How Cheap It Is
Despite a recent earnings win, many investors remain skeptical of its Allergan (AGN) acquisition. The company may not be alone among big ...
STAT
Take This As A Wake-Up Call- Allergan plc (NYSE:AGN)
Allergan plc (NYSE:AGN) reached at $158.25 price level during last trade its distance from 20 days simple moving average was -1.25%, and its ...
Glenrock Gazette - 6 hours ago
Should You Buy Allergan (AGN) Ahead of Earnings?
Investors are always looking for stocks that are poised to beat a t earnings season and Allergan plc AGN may be one such company. The firm ...
Wright Daily
Allergan (AGN) Q2 Earnings & Sales Top, '19 Sales View Up
Allergan plc's AGN second-quarter adjusted earnings came in at $4.38 per share, which beat the Zacks Consensus Estimate of $4.34 and ...


Back